Operon SA, based in Zaragoza, Spain, produces a range of rapid diagnostic test and molecular diagnostic products, which it exports to more than 50 countries. One of Europe’s largest lateral flow test developers, Operon has been developing, manufacturing and selling lateral flow tests to the global market for more than 26 years.
Partnership with Sona
Sona and Operon have signed a collaboration agreement that will see Sona’s nanorod technology integrated into Operon’s market-established lateral flow assays.
The two companies will work together to improve the performance of Operon’s currently in-market lateral flow tests to help further establish their market share in the infectious disease arena.
If the feasibility study is successful, further development will take place with the expectation to launch products into the market in the first half of 2020.
We are confident that Sona’s unique gold nanorods will improve the performance of Operon’s tests while remaining cost-competitive, allowing expansion of their market share in this multi-billion-dollar market segment.
- Press release: Collaboration with major European lateral flow test developer and Sona Nanotech Inc.
- The global lateral flow market is set to reach US $8.7 Billion by 2023
Camino del Plano 19
50410 – Cuarte de Huerva (Zaragoza),